Clinical Trials Directory

Trials / Completed

CompletedNCT01372683

Oat Breakfast Satiety Study

The Effect of Oat Based Breakfast Cereals on Satiety

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
96 (actual)
Sponsor
PepsiCo Global R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is designed to test the hypothesis that on an equivalent calorie basis, oat based breakfast cereals do not provide the same satiety benefit. The study will also demonstrate the satiety comparison of the cereals related to product density.

Detailed description

This study is designed to test the hypothesis that on an equivalent calorie basis, oat based breakfast cereals do not provide the same satiety benefit. The study will also demonstrate the satiety comparison of the cereals related to product density. Ninety-six healthy men and women 18 years of age or older will be enrolled into this study and divided into 2 groups of 48 each to investigate the satiety impact of two oat based breakfast cereals compared to the leading ready-to-eat (RTE) oat based breakfast cereal. Each subject will participate in two test sessions (1 test cereal vs the leading RTE cereal). Subjects will come to the Ingestive Behavior Laboratory between 8 and 10 am after having nothing to eat for 10 hours prior to the scheduled visit time and be given one of the three cereals. The second session will be scheduled at least 1 week after the first. Visual analogue scales of hunger, satiety and subjective energy will be completed at baseline, 30, 60, 120, 180, and 240 minutes. Subjects will return on another day separated by at least a week to repeat the breakfast. Area under the curves of appetite and satiety will be compared with a mixed model.

Conditions

Interventions

TypeNameDescription
OTHERDietary InterventionComparison of oat based breakfast cereals

Timeline

Start date
2011-05-01
Primary completion
2011-10-01
Completion
2011-12-01
First posted
2011-06-14
Last updated
2011-12-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01372683. Inclusion in this directory is not an endorsement.